Dr. Pramod Kumar Mishra, PhD, Chairman
Dr. Pramod Mishra, is a visionary research scientist and entrepreneur from the USA. With a Ph.D. in Microbiology & Immunology from the University of Texas, USA, Dr. Mishra co-founded iGenomeDx in 2016, leading it to become a trailblazer in molecular diagnostics across the USA. His progressive approach combines rigorous compliance with groundbreaking innovation, earning iGenomeDx the “Minority-Owned Business of the Year” award. Dr. Mishra’s dedication to translating science into real-world health solutions reflects his commitment to improving patient care and advancing global healthcare.
Dr. Sanjeev Kumar, General Mngmnt (MIT-Boston) FCMA, FCS, Ph.D., D.Lit.
Director of Corporate Strategies & Legal Affairs
Dr. Sanjeev Kumar, is a versatile leader with extensive experience in corporate strategy, finance, and legal compliance, well-suited to drive success in the healthcare industry. With over 35 years in corporate governance, economic law, and finance, Dr. Kumar brings strategic insight and a robust understanding of complex regulations crucial to healthcare management. He holds advanced degrees, including a PhD, and has studied General Management at MIT’s Sloan School. As Founder and Chairman of BPA Foundation and Managing Director of BPA Advisory Limited, Dr. Kumar’s leadership combines financial acumen with a commitment to advancing healthcare innovation and governance.
Dr. Niti Vanee, PhD, Director
Dr. Niti Vanee, Director of iGenomeDx India, and CEO of iGenomeDx USA. With over a decade in genomics and healthcare entrepreneurship, she spearheads initiatives in pharmacogenomics and infectious disease testing. Her leadership has earned accolades such as the Minority-Owned Business of the Year award from government agencies and Alumni of the Year award from her University. Known for her mentorship and collaborative approach, Dr. Vanee takes keen interest to shape the future biotech professionals. A Ph.D. in Integrative Life Sciences, she drives innovation and patient-centered healthcare.
Mr. Sanjay Kumar Mishra, Senior Vice President
Mr. Sanjay Kumar Mishra brings extensive experience in accounting, multinational banking, and investment banking. With 20 years in the Accounts Branch of the Indian Air Force, he honed skills in store accounting, fund management, and audit coordination. His background includes handling audits, managing non-public funds, and overseeing comprehensive accounting tasks. His recent role as a Senior Analyst in fund accounting further refined his expertise in asset management. Sanjay’s diverse experience and strategic insights make him a vital asset to iGenomeDx, driving financial and operational excellence.
Technology & Innovation
IGenome DX India employs Next-Generation Sequencing (NGS), AI-driven diagnostics, and advanced molecular biology techniques to deliver precise and fast diagnostic results. These technologies help ensure accurate testing and personalized healthcare solutions, including pharmacogenomic insights.
Vision
To transform healthcare in India through technologically advanced and personalized diagnostics, becoming a trusted name in the industry for accurate, reliable, and fast services.
Mission
To be a leader in diagnostics by offering innovative, reliable, and personalized testing solutions, empowering healthcare professionals with fast and accurate results for better patient care.
Core Values
Innovation: Continuously adopting the latest advancements in diagnostics.
Accuracy: Ensuring precise results with every test.
Personalization: Providing tailored healthcare insights through services like pharmacogenomic testing.
Reliability: Delivering consistent, trustworthy results.
Accessibility: Offering services such as home collection and affordable diagnostic packages.